386 Complete/near-complete itch response observed in adult and adolescent patients with moderate-to-severe atopic dermatitis initiating dupilumab treatment in real-world practice

被引:0
|
作者
Bhatia, Neal [1 ]
Lynde, Charles W. [2 ,3 ]
Fonacier, Luz [4 ,5 ]
Tian, Tingting [6 ]
Bosman, Kwinten [7 ]
Korotzer, Andrew [6 ]
机构
[1] Therapeut Clin Res, San Diego, CA USA
[2] Univ Toronto, Markham, ON, Canada
[3] Lynderm Res, Markham, ON, Canada
[4] New York Univ, Langone Hosp Long Isl, Mineola, NY USA
[5] New York Univ, Long Isl Sch Med, Mineola, NY USA
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[7] Sanofi, Amsterdam, Netherlands
关键词
real-world; registry; dupilumab; pruritus;
D O I
10.1093/bjd/ljad162.013
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
386
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kim, Nicole S.
    Maliyar, Khalad
    Oliveira, Luciana
    O'Toole, Ashley
    Gooderham, Melinda J.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (10) : E361 - E363
  • [2] Dupilumab Treatment Rapidly Improves Itch in Patients With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    Chao, Jingdong
    Eckert, Laurent
    Chen, Zhen
    Ardeleanu, Marius
    Shumel, Brad
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Gadkari, Abhijit
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 29 - 29
  • [3] DUPILUMAB TREATMENT RAPIDLY IMPROVES ITCH IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Silverberg, J.
    Chao, J.
    Eckert, L.
    Chen, Z.
    Ardeleanu, M.
    Shumel, B.
    Plaum, S.
    Graham, N.
    Pirozzi, G.
    Gadkari, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S95 - S95
  • [4] Upadacitinib for the treatment of moderate-to-severe atopic dermatitis in real-world clinical practice
    Tran, Vanessa
    Ross, Gayle
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 11 - 11
  • [5] Real-world experience of dupilumab for patients with moderate-to-severe atopic dermatitis in a tertiary care setting
    Kreeshan, F. C.
    Lavery, D.
    Clarke, S.
    Warren, R. B.
    Hunter, H. J. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 70 - 70
  • [6] Efficacy of Dupilumab on Different Phenotypes of Adult with Moderate-to-Severe Atopic Dermatitis in Taiwan: A Real-World Study
    Yang, Chin-Yi
    Lai, Po-Ju
    Chen, Chun-Bing
    Chan, Tom C.
    Hui, Rosaline Chung-Yee
    Huang, Yu-Huei
    Tseng, Han-Chi
    Lin, Shang-Hung
    Lu, Chun-Wei
    Lee, Hua-En
    Lin, Jing-Yi
    Chi, Min-Hui
    Tsai, Ming-Feng
    Hwang, Yih-Shiou
    Wang, Chuang-Wei
    Chu, Chia-Yu
    Chung, Wen-Hung
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)
  • [7] Dupilumab treatment restores skin barrier function in adult and adolescent patients with moderate-to-severe atopic dermatitis
    Goleva, E.
    Bissonnette, R.
    Berdyshev, E.
    Jurvilliers, P.
    Agueusop, I.
    Praestgaard, A.
    Levit, N. A.
    Rossi, A.
    Zhang, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S51 - S51
  • [8] Dupilumab treatment induces rapid clinical improvement of itch in patients with moderate-to-severe atopic dermatitis
    Silverberg, Jonathan I.
    Eckert, Laurent
    Ardeleanu, Marius
    Chen, Zhen
    Akinlade, Bolanle
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozi, Gianluca
    Gadkari, Abhijit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB113 - AB113
  • [9] Retrospective Study of Dupilumab Treatment for Moderate to Severe Atopic Dermatitis in Korea: Efficacy and Safety of Dupilumab in Real-World Practice
    Jang, Dong Hyek
    Heo, Seok Jae
    Jung, Hye Jung
    Park, Mi Yeon
    Seo, Seong Jun
    Ahn, Jiyoung
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 12
  • [10] Real-world effectiveness and safety of dupilumab in managing children and adolescents with moderate-to-severe atopic dermatitis
    Marshall, Claire
    Littlewood, Zoe
    Herety, Nichola
    Heal, Calvin
    Sharif, Jennifer
    Clayton, Tim
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 196 - 196